Neurocysticercosis Diagnosis and Treatment Strategies

Neurocysticercosis arises when Taenia solium larvae invade the central nervous system, forming cysts in brain parenchyma or extraparenchymal spaces. Disease presentation ranges from seizures, headaches and focal neurological deficits to intracranial hypertension. Diagnosis rests on neuroimaging, primarily computed tomography and magnetic resonance imaging, supplemented by serological and cerebrospinal fluid antigen assays that detect parasite antigens or host antibodies. Treatment strategies combine symptomatic management—most notably antiepileptic drugs and intracranial pressure control—with antiparasitic regimens such as albendazole or praziquantel, often in combination with corticosteroids to mitigate inflammatory reactions. Decision algorithms consider cyst burden, location, viability and host immune status, with surgical intervention reserved for obstructive or viable intracranial cysts. Recent advances include refined imaging protocols to distinguish active from degenerating cysts, point-of-care antigen detection assays and tailored dosing schedules aimed at maximising parasite clearance while minimising adverse effects. Globally, integrated control measures addressing sanitation, pig management and community education complement clinical interventions to reduce disease incidence and burden.

Research from Nature Portfolio

Global research priorities for infections affecting the nervous system have emphasised neurocysticercosis as a key target for improved diagnostics and therapeutics. Efforts centre on developing point-of-care assays for parasite antigen detection, validating biomarkers of treatment response and refining imaging modalities to assess lesion viability and host immune activity. These priorities stress vaccine research, novel antiparasitic compounds and durable strategies to prevent neurological sequelae, highlighting the need for interdisciplinary trials in endemic settings to align laboratory innovations with real-world clinical outcomes.

Neurocysticercosis Diagnosis and Treatment Strategies publication trend

The graph below shows the total number of articles in neurocysticercosis diagnosis and treatment strategies across all publications each year (not limited to Nature Index journals).

Technical terms

Neurocysticercosis: Infection of the central nervous system by Taenia solium larval cysts.

Computed tomography (CT): Imaging modality using X-rays to visualise intracranial cysts and calcifications.

Antiparasitic therapy: Pharmaceutical regimen, typically albendazole or praziquantel, to eradicate viable cysticerci.

Cerebrospinal fluid (CSF): The fluid surrounding the brain and spinal cord, analysed for parasite antigens, antibodies and inflammatory markers.

References

1. Clinical Manifestations Associated with Neurocysticercosis: A Systematic Review. PLOS Neglected Tropical Diseases (2011).
2. Global research priorities for infections that affect the nervous system. Nature (2015).
3. Neurocysticercosis: Neglected but Not Forgotten. PLOS Neglected Tropical Diseases (2012).
4. Extraparenchymal neurocysticercosis: Demographic, clinicoradiological, and inflammatory features. PLOS Neglected Tropical Diseases (2017).
5. Neurocysticercosis as a Cause of Epilepsy and Seizures in Two Community-Based Studies in a Cysticercosis-Endemic Region in Peru. PLOS Neglected Tropical Diseases (2014).